![Sean Cassidy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sean Cassidy
Direttore/Membro del Consiglio presso
HOOA PHARPAR
Profilo
Attualmente, Sean A. Cassidy è direttore finanziario di Arvinas, Inc., direttore finanziario di Arvinas Operations, Inc. (una consociata di Arvinas, Inc.) e Tesoriere di The Friends of Yale New Haven Children's Hospital. In passato il signor Cassidy ha ricoperto la posizione di direttore finanziario e vicepresidente dell'amministrazione presso Renetx Bio, Inc., direttore finanziario e vicepresidente per CuraGen Corp., direttore e controllore presso Deloitte & Touche LLP e direttore e controllore presso 454 Life Sciences Corp. Ha ricevuto un MBA e una laurea presso l'Università del Connecticut.
Posizioni attive di Sean Cassidy
| Società | Posizione | Inizio |
|---|---|---|
| HOOA PHARPAR | Direttore/Membro del Consiglio | 22/07/2024 |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Direttore Finanziario/CFO | - |
The Friends of Yale New Haven Children's Hospital | Treasurer | - |
Abbratech, Inc.
 Abbratech, Inc. BiotechnologyHealth Technology Develops antibodies | Direttore/Membro del Consiglio | - |
Renetx Bio, Inc.
 Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Sean Cassidy
| Società | Posizione | Fine |
|---|---|---|
| ARVINAS, INC. | Direttore Finanziario/CFO | 29/02/2024 |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Direttore Finanziario/CFO | 01/06/2013 |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Direttore Finanziario/CFO | 01/10/2009 |
454 Life Sciences Corp.
 454 Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides medical testing services to determine the nucleotide sequence of whole genomes | Direttore/Membro del Consiglio | 01/12/2008 |
| ░░░░░░░░ ░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Sean Cassidy
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
99
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Health Technology |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
454 Life Sciences Corp.
454 Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides medical testing services to determine the nucleotide sequence of whole genomes | Health Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
The Friends of Yale New Haven Children's Hospital | |
HOOKIPA Pharma, Inc.
 HOOKIPA Pharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers | Health Technology |
Abbratech, Inc.
Abbratech, Inc. BiotechnologyHealth Technology Develops antibodies | Health Technology |
